Pharmaceutical composition for the treatment or prevention...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/353 (2006.01) A61K 31/343 (2006.01)

Patent

CA 2595564

Provided is a pharmaceutical composition for the treatment and prevention of obesity, diabetes, metabolic syndromes, degenerative diseases and mitochondrial dysfunction-related diseases, comprising: a therapeutically effective amount of a compound represented by Formula I below, or a pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, and a pharmaceutically acceptable carrier, a diluent or an excipient, or any combination thereof.

L'invention concerne une composition pharmaceutique destinée au traitement et à la prévention de l'obésité, du diabète, des syndromes métaboliques, des maladies dégénératives, et des maladies liées à une dysfonction mitochondriale. Cette composition comprend: une dose thérapeutiquement efficace d'un composé représenté par la formule I ci-dessous, ou un sel, un promédicament, un solvate ou un isomère pharmaceutiquement acceptable de celui-ci, et un véhicule, un diluant ou un excipient pharmaceutiquement acceptables, ou une combinaison quelconque de ceux-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical composition for the treatment or prevention... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for the treatment or prevention..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for the treatment or prevention... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1587898

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.